We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
151
BioMarin Pharmaceuticals
BMRN
$13.5B
$3.33M 0.11%
+40,387
New +$3.36M
NNN icon
152
NNN REIT
NNN
$8.71B
$3.32M 0.11%
77,998
+2,915
+4% +$121K
PWR icon
153
Quanta Services
PWR
$101B
$3.31M 0.11%
13,042
-219
-2% -$58K
MMM icon
154
3M
MMM
$94.4B
$3.31M 0.11%
32,417
+3,353
+12% +$327K
CDNS icon
155
Cadence Design Systems
CDNS
$90.2B
$3.31M 0.11%
10,755
-79
-0.7% -$23.4K
SHW icon
156
Sherwin-Williams
SHW
$88.5B
$3.28M 0.11%
10,998
-180
-2% -$55.7K
MSA icon
157
Mine Safety
MSA
$7.44B
$3.28M 0.11%
17,467
-289
-2% -$53.7K
BURL icon
158
Burlington
BURL
$22.6B
$3.26M 0.11%
13,584
-516
-4% -$106K
ATR icon
159
AptarGroup
ATR
$8.57B
$3.26M 0.11%
23,121
+291
+1% +$42.1K
TTEK icon
160
Tetra Tech
TTEK
$9.06B
$3.25M 0.11%
79,395
-1,890
-2% -$77K
MUR icon
161
Murphy Oil
MUR
$5.12B
$3.24M 0.11%
78,642
-1,458
-2% -$63.5K
ELF icon
162
e.l.f. Beauty
ELF
$5.61B
$3.23M 0.11%
15,306
-2,339
-13% -$416K
UNM icon
163
Unum
UNM
$14.2B
$3.22M 0.11%
63,065
-2,224
-3% -$115K
GNTX icon
164
Gentex
GNTX
$5.04B
$3.18M 0.11%
94,472
-2,330
-2% -$80.5K
SRPT icon
165
Sarepta Therapeutics
SRPT
$1.92B
$3.18M 0.11%
+20,105
New +$2.58M
ROP icon
166
Roper Technologies
ROP
$39.5B
$3.16M 0.11%
5,603
-17
-0.3% -$9.16K
WSO icon
167
Watsco Inc
WSO
$13.2B
$3.15M 0.11%
6,809
-88
-1% -$40.2K
CFR icon
168
Cullen/Frost Bankers
CFR
$10.3B
$3.14M 0.11%
30,923
-476
-2% -$49.9K
SF
169
Stifel
SF
$12.7B
$3.12M 0.11%
55,638
-1,094
-2% -$58K
RNR icon
170
RenaissanceRe
RNR
$13.2B
$3.11M 0.11%
13,936
-182
-1% -$40.8K
MKC icon
171
McCormick & Company Non-Voting
MKC
$14.2B
$3.07M 0.11%
43,291
+1,177
+3% +$85.7K
MCD icon
172
McDonald's
MCD
$194B
$3.05M 0.1%
11,953
+16
+0.1% +$4.25K
NFG icon
173
National Fuel Gas
NFG
$7.82B
$3.04M 0.1%
56,135
-9,190
-14% -$504K
LOW icon
174
Lowe's Companies
LOW
$124B
$3.04M 0.1%
13,769
-202
-1% -$46.1K
BCD icon
175
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF
BCD
$414M
$3.03M 0.1%
93,587
+8,678
+10% +$285K

Similar funds

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.